New modeling research challenges public health guidelines that recommend conservative antibiotic use for cholera. In some cases, prescribing antibiotics more broadly could slow or stop outbreaks and even reduce the risk of antibiotic resistance.
Ludwig Cancer Research is proud to support eight early-career scientists presenting their research at the conference this year through the AACR Scholar-in-Training Awards (SITA) program, contributing to the cost of their travel and attendance at the conference.
Kowa Company, Ltd. (Headquarters: Nagoya, Aichi Prefecture, Japan), today announced an upcoming presentation of non-clinical data for K-679, its novel antibody drug-loaded unimicelle conjugate (ADUC) with unprecedented drug loading capacity.
Wound healing has been termed “an overlooked burden and a silent epidemic” due to the significant financial strain that it places on healthcare systems, let alone the unquantifiable human cost.
GemPharmatech Significantly Expands U.S. Capabilities with New San Diego Biotech Hub Facility
Research in the Sundquist lab laid the foundations for the development of lenacapavir, a drug that prevents HIV infection with 99.9% to 100% efficacy and could dramatically lower infection rates worldwide.
As many as 10% of people with epilepsy taking antiseizure medications also take medications to lower the risk of blood clots. Many are prescribed direct-acting oral anticoagulants, or DOACs. But how DOACs interact with antiseizure medications, particularly newer-generation medications, is still not clear.
A new study from researchers in the at Washington University in St. Louis reveals the impact of what might may be precursors to harmful contaminants in drinking water, formed during water disinfection.
UdeM pharmacy professor Simon Matoori has reviewed studies on the therapeutic properties of honey in the treatment of both acute and chronic wounds.
ProBio, a global leader in the antibody discovery and development, is pleased to announce its upcoming poster presentation at the American Association for Cancer ResearchⓇ (AACR) 116th Annual Meeting, to be held April 25 to 30, 2025, at the McCormick Place Convention Center in Chicago, Illinois.
Scientists at St. Jude Children’s Research Hospital explored selectively blocking the CYP3A4 protein responsible for breaking down large swaths of approved drugs, providing a way to improve drug efficacy.
20240921121116.png&width=400&height=400){kind=logo}
Results presented during oral presentation at the American Academy of Neurology 2025 Annual Meeting
A worryingly wide range of chemical pollutants has been found by researchers studying two of the UK’s south-coast harbours, raising concerns about the impact on wildlife and the human activities responsible for this contamination.
Viruses known as “jumbo phage” are a new hope against the rising antibacterial infection crisis. Researchers have discovered how jumbo phage are able to infect bacteria so efficiently. They found a compartment that protects and hides valuable DNA material from the bacteria’s immune defense system.
A second-generation compound outperforms predecessor in the fight against coronavirus.
A powerful new software platform called the Playbook Workflow Builder is set to transform biomedical research by allowing scientists to conduct complex and customized data analyses without advanced programming skills. An article that describes the new platform was published in the April 3 online issue of the journal PLOS Computational Biology. Developed by a multi-institutional team that was led by Icahn School of Medicine at Mount Sinai investigators as part of the National Institutes of Health Common Fund Data Ecosystem (CFDE) program, researchers from across the United States developed the web-based platform that enables scientists to analyze and visualize their own data independently through an intuitive, interactive interface.
"I, Ovosan" offers inspiring cancer survivor stories interwoven with cutting-edge research, detailing the development and therapeutic potential of Ovosan's bioactive phospholipids, now available in the US as CellBB.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right